| Basics |
|
OmniAb, Inc.
|
| IPO Date: |
September 30, 2021 |
| Sector: |
Healthcare |
| Industry: |
Biotech |
| Market Cap: |
$238.97M |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.10 | 2.64%
|
| Avg Daily Range (30 D): |
$0.04 | 2.57%
|
| Avg Daily Range (90 D): |
$0.05 | 2.65%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.55M |
| Avg Daily Volume (30 D): |
.39M |
| Avg Daily Volume (90 D): |
.41M |
| Trade Size |
| Avg Trade Size (Sh.): |
116 |
| Avg Trade Size (Sh.) (30 D): |
138 |
| Avg Trade Size (Sh.) (90 D): |
127 |
| Institutional Trades |
| Total Inst.Trades: |
110 |
| Avg Inst. Trade: |
$1.51M |
| Avg Inst. Trade (30 D): |
$1.13M |
| Avg Inst. Trade (90 D): |
$1.11M |
| Avg Inst. Trade Volume: |
.5M |
| Avg Inst. Trades (Per Day): |
1 |
| Market Closing Trades |
| Avg Closing Trade: |
$1.58M |
| Avg Closing Trade (30 D): |
$.88M |
| Avg Closing Trade (90 D): |
$.98M |
| Avg Closing Volume: |
451.35K |
|
|
| Financials |
| |
TTM |
Q1 2025 |
Q4 2024 |
|
Basic EPS
|
$-.15
|
$-.17
|
$-.13
|
|
Diluted EPS
|
$-.15
|
$-.17
|
$-.13
|
|
Revenue
|
$ 3.9M
|
$ 4.15M
|
$ 10.8M
|
|
Gross Profit
|
$
|
$
|
$
|
|
Net Income / Loss
|
$ -15.88M
|
$ -18.2M
|
$ -13.07M
|
|
Operating Income / Loss
|
$ -16.22M
|
$ -18.84M
|
$ -15.88M
|
|
Cost of Revenue
|
$
|
$
|
$
|
|
Net Cash Flow
|
$ 7.39M
|
$ -16.71M
|
$ .36M
|
|
PE Ratio
|
|
|
|
|
|
|